GLPwatch

Saxenda vs Trulicity

Drug comparison

Last updated 2026-05-28 15:46 UTC

Saxenda (liraglutide by Novo Nordisk) is an injectable prescription medicine approved for treating obesity, while Trulicity (dulaglutide by Eli Lilly) is an injectable prescription medicine approved for treating type 2 diabetes and reducing cardiovascular risk. Both are given as a once-weekly shot under the skin, but Saxenda is used for weight management in people with obesity, whereas Trulicity is used to control blood sugar and protect the heart in people with type 2 diabetes.

AI summary of the sources below.

Saxenda Trulicity
Active ingredientliraglutidedulaglutide
Manufacturernovo-nordiskeli-lilly
Routesubcutaneous injectionsubcutaneous injection
FDA-approved forobesitytype 2 diabetes, cardiovascular risk reduction
Label updated2026-02-252023-08-05

Compare full details on the Saxenda and Trulicity pages.